EyePoint settles False Claims Act case regarding DEXYCU marketing.
EyePoint Inc. agreed to settle a lawsuit brought by the US government related to kickbacks for its drug DEXYCU. This legal resolution mitigates potential liability but signals significant regulatory scrutiny for the company.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day